Beta-adrenergic agonists typically end in which suffix?

Beta-adrenergic agonists typically end in which suffix?

• A. End in 'erol' (albuterol)
• B. End in 'pril' (lisinopril)
• C. End in 'sartan' (losartan)
• D. End in 'pine' (amlodipine)

Answer: (A)

Beta-adrenergic agonists are bronchodilators that stimulate beta receptors to relax airway smooth muscle. A handy naming clue for this class is the suffix -erol, as seen in drugs like albuterol. That -erol ending signals a beta-adrenergic agonist commonly used to treat asthma or COPD by widening the airways. The other endings correspond to different drug classes: -pril indicates ACE inhibitors (for example, lisinopril), -sartan marks ARBs (such as losartan), and -pine is typical of certain calcium channel blockers (like amlodipine). So the -erol suffix helps you recognize beta-adrenergic agonists quickly.

Beta-adrenergic agonists are bronchodilators that stimulate beta receptors to relax airway smooth muscle. A handy naming clue for this class is the suffix -erol, as seen in drugs like albuterol. That -erol ending signals a beta-adrenergic agonist commonly used to treat asthma or COPD by widening the airways. The other endings correspond to different drug classes: -pril indicates ACE inhibitors (for example, lisinopril), -sartan marks ARBs (such as losartan), and -pine is typical of certain calcium channel blockers (like amlodipine). So the -erol suffix helps you recognize beta-adrenergic agonists quickly.